Kidney disease decisions — 2025

The appeal seeking service connection for kidney disease/disorder was dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted service connection for multiple myeloma, Parkinson's disease, diabetes mellitus type II (DMII), and kidney failure secondary to DMII based on in-service herbicide exposure.

The Board denied service connection for GERD, pancreatitis, kidney disease, and Barrett's Esophagus as the evidence did not support a nexus between these conditions and the Veteran's active service.

The Board denied service connection for diabetes mellitus, kidney dysfunction, and hearing loss due to lack of evidence supporting a current diagnosis or nexus to service.

The Board granted service connection for diabetes mellitus, diabetic neuropathy of both lower extremities, and kidney disease, all as secondary to the Veteran's service-connected diabetes mellitus.

The Board granted service connection for right hip trochanteric pain syndrome and remanded the claim for service connection for kidney stones.

The Board granted service connection for diabetes, hypertension, monoclonal gammopathy, diabetic peripheral neuropathy of the bilateral femoral and sciatic nerves, chronic kidney disease, anemia, and upper extremity diabetic peripheral neuropathy on a direct basis or secondary to diabetes, effective November 5, 2021.

The Board granted an effective date of July 3, 2019 for the grant of service connection for urolithiasis/kidney stones and denied earlier effective dates for other claims.

The Veteran's claims for earlier effective dates for service connection were granted, while the claim for a compensable rating for hypertension was denied. A 40 percent rating was granted for diabetes mellitus type II with retinopathy.

The Board denied service connection for a kidney transplant (claimed as kidney failure) due to the lack of evidence linking it to active duty, including toxic exposure risk activities.

The Board remands the claims for service connection for kidney cancer and bone cancer due to a need for additional evidence and an addendum opinion.

The Board denied service connection for various conditions, including bilateral hearing loss, tinnitus, prostatitis, kidney stones, and multiple other disabilities. The earlier effective date claim was also denied.

The Board granted service connection for the cause of death due to end stage renal disease and hypertension, which were attributed to in-service herbicide exposure.

The Board granted service connection for bilateral hearing loss, resolving all reasonable doubt in favor of the Veteran. The claim for chronic kidney disease was remanded for further development.

The Board dismissed the appeals for service connection for cystic kidney disease and heart disease, as well as denied a rating in excess of 20 percent for prostate cancer.

The Board granted service connection for rhinitis and dismissed the claims for kidney disease, special monthly compensation based on need for aid and attendance, and other conditions that were remanded.

The Board granted service connection for renal cancer, for purposes of accrued benefits, resolving reasonable doubt in favor of the Veteran's surviving spouse.

The Board remands the matter of entitlement to an initial rating in excess of 60 percent for service-connected chronic kidney disease due to a pre-decisional duty to assist error.

The Board granted service connection for prostate cancer, chronic renal disease, and hypertension due to presumed exposure to contaminated water at Camp Lejeune. Service connection was also granted for depression related to the Veteran's service-connected tinnitus. The claims for service connection for lymphedema, a back condition, gout, a right toe condition, a left ankle condition, diabetes mellitus, bilateral leg clots, bilateral lower extremity neurological conditions, and erectile dysfunction were denied or remanded.

The Board remands the matter of entitlement to service connection for a kidney disorder, including chronic UTI, pyelonephritis, nephrolithiasis, and MSK, due to further development needed.